Stephanie Hawthorne
About Stephanie Hawthorne
Stephanie Hawthorne is the Associate Director of North America Cell Therapy Scheduling at Bristol Myers Squibb, with extensive experience in genomics, cell logistics, and medical informatics.
Title and Current Position
Stephanie Hawthorne is currently the Associate Director, North America Cell Therapy Scheduling at Bristol Myers Squibb. She leads a team responsible for the scheduling and logistics of cell therapy treatments across North America. Her role involves optimizing cell therapy scheduling processes to improve patient outcomes.
Previous Roles at Bristol Myers Squibb
Before her current role, Stephanie served as the Senior Manager, Scheduling and Cell Logistics at Bristol Myers Squibb. From 2020 to 2021, she was based in Seattle, Washington, where she contributed to the logistics and scheduling within the cell therapy domain.
Experience at University of Washington
Stephanie Hawthorne worked at the University of Washington in various roles. From 2015 to 2020, she was the Director Of Operations at the Northwest Genomics Center. Previously, she served as a Research Coordinator in Genome Sciences, Nickerson Lab from 2013 to 2015. Her work involved significant projects related to genome sciences and operations management.
Background in Histotechnology
Stephanie has an extensive background in histotechnology. She worked at the New York State Histotechnological Society as the Advertising Coordinator and Layout Editor from 2009 to 2014. Additionally, she was a Sr. Research Technician at NYU Medical Center from 2009 to 2013 and held roles as a Histology Lab Assistant at Sacred Heart Medical Center and Incyte Pathology in 2007 and 2006, respectively.
Education and Expertise
Stephanie holds a Master of Health Administration in Medical Informatics from Saint Joseph's University, obtained between 2012 and 2015. She also earned a Bachelor of Science in Biology from Gonzaga University from 2004 to 2007. Her educational background in medical informatics and biology supports her expertise in managing complex scheduling systems for cell therapy.